- AMC
- Nippon India Mutual Fund
- Category
- Sectoral Fund
- ISIN
- INF204K01950
Nippon India Pharma Fund
₹531.1304
−₹5.5080 (−1.03%)
NAV · Regular · Bonus ·
Nippon India Pharma Fund's Regular Bonus NAV was ₹531.1304 on 19 Oct 2026, down 1.03% on the day. Its 3-year return is 14.89% a year.
- Expense ratio
- 1.85%
- Fund size
- ₹8,513.05 Cr
- Min. investment
- ₹5,000
NAV history
Between 20 Oct 2025 and 19 Oct 2026, the NAV ranged from ₹481.8247 to ₹581.0418.
Regular · Bonus plan. 3Y, 5Y and since-launch returns are annualised; since launch is absolute until the fund is a year old.
Fund details
- Expense ratio
- 1.85% (Regular)
- Exit load
- 1% if redeemed or switched out within 1 month from allotment, nil thereafter
- Riskometer
- Very high
- Benchmark
- BSE Healthcare TRI
- Launched
- 10 May 2004
- Fund managers
- Sailesh Raj Bhan
Fund size, expense ratio and minimums as of 16 Oct 2026.
All plans
| Plan | ISIN | NAV | 1 day | Expense ratio | 1 year |
|---|---|---|---|---|---|
| Direct · Growth | INF204K01I50 | ₹598.1491 | −1.02% | 1.85% | +4.29% |
| Regular · Growth | INF204K01968 | ₹531.1304 | −1.03% | 1.85% | +3.38% |
| Direct · IDCW | INF204K01I35 | ₹163.7007 | −1.02% | 1.85% | −3.34% |
| Regular · IDCW | INF204K01935 | ₹114.6945 | −1.03% | 1.85% | −4.22% |
| Direct · Bonus | INF204K01I27 | ₹598.1491 | −1.02% | 1.85% | +4.29% |
| Regular · Bonus | INF204K01950 | ₹531.1304 | −1.03% | 1.85% | +3.38% |
All plans hold the same portfolio. They differ in expense ratio (Direct plans pay no distributor commission) and in how gains are handled (Growth reinvests, IDCW pays out).
Armor risk check
Nippon India Pharma Fund moves about as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appAbout this fund
Nippon India Pharma Fund is an open-ended mutual fund from Nippon India Mutual Fund, in the Sectoral Fund category. It began on 10 May 2004. It is benchmarked to the BSE Healthcare TRI. The fund manages ₹8,513.05 Cr across its plans as of 16 Oct 2026. The Regular · Bonus plan has an expense ratio of 1.85%. The minimum first investment is ₹5,000, and SIPs are available.
FAQs
What is the NAV of Nippon India Pharma Fund?
The NAV of Nippon India Pharma Fund (Regular · Bonus) was ₹531.1304 on 19 Oct 2026, down 1.03% from the previous NAV.
What plans does Nippon India Pharma Fund have?
Nippon India Pharma Fund has 6 plans: Direct · Growth; Regular · Growth; Direct · IDCW; Regular · IDCW; Direct · Bonus; Regular · Bonus.
What is the expense ratio of Nippon India Pharma Fund?
The Regular · Bonus plan of Nippon India Pharma Fund has an expense ratio of 1.85%.
What is the fund size (AUM) of Nippon India Pharma Fund?
Nippon India Pharma Fund manages ₹8,513.05 Cr across all plans as of 16 Oct 2026.
What returns has Nippon India Pharma Fund delivered?
Nippon India Pharma Fund returned +3.38% over 1Y, +14.89% a year over 3Y, +11.65% a year over 5Y. Past performance does not guarantee future returns.
What is the exit load of Nippon India Pharma Fund?
Nippon India Pharma Fund: 1% if redeemed or switched out within 1 month from allotment, nil thereafter.
What is the minimum investment and SIP amount for Nippon India Pharma Fund?
The minimum first investment in Nippon India Pharma Fund is ₹5,000, and ₹1,000 after that. SIPs are available (SIP available Monthly (Rs.100-5000), Quarterly (Rs.500-1500), Yearly (Rs.5000). Minimum 6-60 installments based on amount. Dates: 1st to 31st of month.).
How risky is Nippon India Pharma Fund?
Nippon India Pharma Fund is rated "very high risk" on SEBI's riskometer.
For information only. Not investment advice or a research report. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.
Full disclaimerSee how Nippon India Pharma Fund fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app